{"id":"NCT00598273","sponsor":"Affymax","briefTitle":"Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis","officialTitle":"AFX01-11: A Phase 3, Randomized, Active-controlled, Open-label, Multi-center Study of the Safety and Efficacy of Peginesatide for the Correction of Anemia in Patients With Chronic Renal Failure (CRF) Not on Dialysis and Not on Erythropoiesis Stimulating Agent (ESA) Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2009-03","completion":"2010-02","firstPosted":"2008-01-21","resultsPosted":"2012-07-30","lastUpdate":"2013-02-12"},"enrollment":490,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Renal Failure","Chronic Kidney Disease","Anemia"],"interventions":[{"type":"DRUG","name":"peginesatide","otherNames":["Omontys","Hematide","AF37702 Injection"]},{"type":"DRUG","name":"peginesatide","otherNames":["Omontys","Hematide","AF37702 Injection"]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":["Aranesp"]}],"arms":[{"label":"Peginesatide 0.025 mg/kg","type":"EXPERIMENTAL"},{"label":"Peginesatide 0.04 mg/kg","type":"EXPERIMENTAL"},{"label":"Darbepoetin Alfa","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to evaluate the safety and efficacy of peginesatide for the treatment of anemia in participants with chronic kidney disease, who are not on dialysis and not on erythropoiesis stimulating agent (ESA) treatment.","primaryOutcome":{"measure":"Mean Change in Hemoglobin Between Baseline and the Evaluation Period","timeFrame":"Baseline and Weeks 25-36","effectByArm":[{"arm":"Peginesatide 0.025 mg/kg","deltaMin":10.05,"sd":0.623},{"arm":"Peginesatide 0.04 mg/kg","deltaMin":9.95,"sd":0.685},{"arm":"Darbepoetin Alfa","deltaMin":10.05,"sd":0.638}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":72,"countries":["United States","Puerto Rico"]},"refs":{"pmids":["23343062","23343061"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":77,"n":161},"commonTop":["Hyperkalaemia","Oedema peripheral","Urinary tract infection","Nausea","Diarrhoea"]}}